Headquarters
9422 S 51ST ST, PHOENIX, AZ 85044-5684, US
PHOENIX, AZ, US
CORTEXA THERAPEUTICS, INC.
From the company
Cortexa Therapeutics is a neuroscience company developing therapies that target biological mechanisms shared across neurodegenerative diseases to restore neuronal homeostasis. Its first program, CRTX-101, targets calcium-permeable AMPA receptors (CP-AMPARs) as mediators of excitotoxic calcium overload in ALS. The company was founded by Nathan Cole following his ALS diagnosis at age 31 and is advised by a scientific board spanning motor neuron biology, ALS neurobiology and excitotoxicity, and translational neurodegeneration research.
Products & services offered
Capabilities 3
Classifications
- Ownership classifications (2)
- Service Disabled Veteran Owned Business, Veteran Owned Business
Facilities
Send your requirements
Quantities, certifications, and timing.